X
<

What Investors Should Know about Ashland's Debt Position

PART:
1 2 3 4
Part 3
What Investors Should Know about Ashland's Debt Position PART 3 OF 4

What Analysts Recommend for Ashland

Analysts’ consensus on Ashland

As of September 28, 11 analysts are actively tracking Ashland. Among them, 72% of analysts have recommended the stock as a “buy,” 28% of analysts have recommended the stock as a “hold,” while none of the analysts have recommended the stock as a “sell.”

What Analysts Recommend for Ashland

Interested in BRO? Don't miss the next report.

Receive e-mail alerts for new research on BRO

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

Analysts’ consensus indicates Ashland’s 12-month target price to be at $73.13, implying a return potential of 11.5% from the closing price of $65.60 as of September 28, 2017.

Many analysts are recommending a “buy”

ASH completed the acquisition of Pharmachem in fiscal 3Q17, which is expected to contribute to ASH’s top-line growth. Also, the recovery in butanediol prices has led ASH to increase prices of a few of its products across several regions. As a result, ASH’s fiscal 4Q17 earnings could see good growth. Thus, most analysts are recommending a “buy.”

Individual brokerage firms’ views

  • Jeffries rated Ashland as a “buy” and recommended a target price of $77, implying a return potential of 17.4% over the closing price of $65.60 as of September 28, 2017.
  • Suntrust Robinson has recommended a target price of $74, implying a return potential of 12.8% over the closing price of $65.60 as of September 28, 2017.
  • Deutsche Bank (DB) has rated Ashland as a “buy” with a target price of $74, implying a return potential of 12.8% from the closing price of $65.60 as of September 28, 2017.

Investors looking for exposure to ASH can invest in the PowerShares S&P MidCap Low Volatility Portfolio (XMLV), which invests 1.3% of its portfolio in Ashland. The fund also provides exposure to Brown & Brown (BRO) and Westar Energy (WR), which have weights of 1.7% and 1.6%, respectively, as of September 28, 2017.

X

Please select a profession that best describes you: